Leading Cancer Diagnostics Market Players

Strategic Assessments of Major Suppliers and Emerging Market Entrants

Publication Date	September 2009
Publisher	Venture Planning Grp.
Product Type	Report
Pages	80
ISBN Number	not applicable
Product Code	VEP00248

Buy this product or for assistance call +44 20 7060 7474

PDF £1,325.00$2204 | €1483

FAX Order above formats by FAX

Summary

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies

Content

Companies Mentioned
- Abbott
- AdnaGen
- Agensys
- Altana
- Ambrilia Biopharma
- AMDL
- BD
- Beckman Coulter
- Biofield
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- Biotrol/B. Braun
- CeMines
- Cepheid
- CIS/BIO
- Cliniqa
- Correlogic Systems
- Cytyc
- Daiichi
- DakoCytomation
- diaDexus
- DiagnoCure
- Diagnostic Systems
- Dianon
- DiaSorin
- Digene
- Eiken
- Enterix
- Enzo Biochem
- Epigenomics
- Exact Sciences
- Fujirebio
- Gen-Probe
- Gene Logic
- Green Cross
- Grifols-Quest
- Guided Therapeutics
- Ibex Technologies
- Immunicon
- Ipsogen
- Kyowa Medex
- Matritech
- Molecular Diagnostics
- Myriad Genetics
- Nippon Flour Mills
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Quest Diagnostics Nichols Institute
- Roche Diagnostics
- Scantibodies
- Siemens
- Targeted Diagnostics
- Tosoh
- Trylon
- Wako Chemicals
- Worldwide Medical
- Zila